Skip to content
Home/Companies/Biotech/ReNeuron Group

ReNeuron Group

Biotech·UK·Exited 2024
Entry
–
Hold
–
Exit
2024

Who owns ReNeuron Group?

ReNeuron Group was owned by Obotritia Capital through Obotritia Capital KGaA (2014 vintage).

Hand-verified · updated 2026-05-27

Obotritia Capital
Investor
Obotritia Capital
Obotritia Capital KGaA · 2014 · Real Estate

Key facts

HQUnited Kingdom
SectorBiotech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2024

More from Obotritia Capital KGaA

Other portfolio companies in the same fund.

Towerview Healthcare Group Ltd
Active
United Kingdom
Readcrest Capital AG
Readcrest Capital AG
Active
Real EstateGermany· 2025
F.C. Hansa Rostock
F.C. Hansa Rostock
Active
ConsumerGermany· 2024
Arrago
Arrago
Active
FinancialsFrance· 2023
Bitbond
Active
FintechGermany· 2017
Bankhaus Obotritia
Exited 2025
FinancialsGermany· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track ReNeuron Group

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy ReNeuron Group?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on ReNeuron Group.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue